Home / Import refusals / 8GX-8000731-3/11/1

FDA Import Refusal 8GX-8000731-3/11/1 — Zhejiang Peptites Biotech Co.,Ltd.

Zhejiang Peptites Biotech Co.,Ltd. — FEI 3015685285

The FDA refused shipment 8GX-8000731-3/11/1 from Zhejiang Peptites Biotech Co.,Ltd. (China) on September 7, 2023. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 2280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 7, 2023
Country
China
Product Category
Drugs and Biologics
Product Code
61PCT72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
2280

Recent inspections

  • 1220833 (VAI Fri Sep 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • F57-1763835-1/11/1 (Wed Mar 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9672874-7/11/1 (Fri Mar 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 906-0393549-8/11/1 (Wed Jan 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 906-0398737-4/11/1 (Wed Jan 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 300-6548574-2/11/1 (Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources